PLAUR and ovarian carcinoma: Inhibition of α6 or β1 integrin or uPAR signalling pathway inhibited ascites-induced activation of Ras and Erk pathway with subsequent inhibition in proliferation, adhesion and invasion of ovarian cancer cells.